Form D · Pharmaceuticals
XYNOMIC PHARMACEUTICALS HOLDINGS, INC.
Shanghai, F4 · CIK 0001697805
Offering snapshot reported Jul 15, 2019 · SEC filing
- Reported sold
- Yet to sell Offering amount: $15M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 15, 2019 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-344248
The company does not engage any placement agents for this offering and therefore, this item is not applicable.
Source: Form D, filed Jul 15, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Folinsbee | Director |
| Adam Inglis | Director |
| Jinwei Coco Kou | Executive |
| Charles Vincent Prizzi | Director |
| Tingzhi Qian | Director |
| Jiayuan James Tong | Director, Executive |
| Peidong Richard Wu | Director |
| Wentao Jason Wu | Executive |
| Yinglin Mark Xu | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1010 Middle Huaihai Road Suite 3306, K. Wah Centre
Shanghai, F4, 200031
Shanghai, F4, 200031